Your search returned 6 results.

Results
	1.	The intestinal uptake of phenol from micellar systems does not conform to the aqueous transfer model. [electronic resource] by Kothare, P A Zimmerman, C L Producer: 20010118 In: Pharmaceutical research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetes. [electronic resource] by Linnebjerg, H Kothare, P A Seger, M Wolka, A M Mitchell, M I Producer: 20110324 In: International journal of clinical pharmacology and therapeutics vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects. [electronic resource] by Linnebjerg, H Seger, M Kothare, P A Hunt, T Wolka, A M Mitchell, M I Producer: 20111129 In: International journal of clinical pharmacology and therapeutics vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Exenatide effects on statin pharmacokinetics and lipid response. [electronic resource] by Kothare, P A Linnebjerg, H Skrivanek, Z Reddy, S Mace, K Pena, A Han, J Fineman, M Mitchell, M Producer: 20070315 In: International journal of clinical pharmacology and therapeutics vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes. [electronic resource] by Linnebjerg, H Kothare, P A Skrivanek, Z de la Peña, A Atkins, M Ernest, C S Trautmann, M E Producer: 20060814 In: Diabetic medicine : a journal of the British Diabetic Association vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Leveraging a Clinical Phase Ib Proof-of-Concept Study for the GPR40 Agonist MK-8666 in Patients With Type 2 Diabetes for Model-Informed Phase II Dose Selection. [electronic resource] by Krug, A W Vaddady, P Railkar, R A Musser, B J Cote, J Ederveen, Agh Krefetz, D G DeNoia, E Free, A L Morrow, L Chakravarthy, M V Kauh, E Tatosian, D A Kothare, P A Producer: 20180618 In: Clinical and translational science vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)